| Study name |
Randomized controlled trial for intermittent fasting therapy for nonalcoholic fatty liver disease |
| Methods |
Randomised controlled trial |
| Participants |
Inclusion criteria
(1) patients with nonalcoholic fatty liver disease
(2) age 18‐70 years old
(3)Light physical labourers
(4) participants are required to sign informed consent
Exclusion criteria
(1) other liver diseases and drug‐induced liver damage
(2) diabetic patients (FPG = 7.0mmol/L and/or OGTT 2‐hour PG=11.1mmol/L)
(3) hypertensive patients (systolic blood pressure =140 mmHg and / or diastolic blood pressure = 90 mmHg or taking antihypertensive drugs)
(4) those who participated in the study three months before, or participated in other research trials at the same time
(5) those who were enrolled in the study three months ago, or at the same time
(6) obvious renal insufficiency (creatinine = 1.5 mg/dL or > 133umol/L)
(7) those who have had a history of stroke or myocardial infarction
(8) have done or are preparing for coronary balloon dilatation or coronary artery bypass surgery
(9) suffering from other serious diseases such as malignant tumours
(10) pregnant or lactating women
(11)participant considered by the investigator not suitable for inclusion |
| Interventions |
1:Health education, sports guidance,Intermittent fasting for 1 day per week;2:Health education, sports guidance,Intermittent fasting for 2 days per week;3:Health education, sports guidance; |
| Outcomes |
BMI; waist circumference; hip circumference; waist‐to‐hip ratio; liver function; |
| Starting date |
2019‐07‐01 |
| Contact information |
fan_yibing@163.com |
| Notes |
|
